Parvalbumin is a calcium-binding protein expressed in specific neuronal populations, primarily fast-spiking interneurons. It plays important roles in neuronal excitability, synaptic inhibition, and has been implicated in various neurodegenerative diseases.
Parvalbumin is a small (~11 kDa) protein belonging to the EF-hand family of calcium-binding proteins. It is characterized by:
- High affinity for calcium (Kd ~10^-7 M)
- Fast on/off kinetics for calcium binding
- Selective expression in specific neuron types
The protein is encoded by the PVALB gene on chromosome 22q12.
Parvalbumin has the classic EF-hand structure:
- Six alpha-helices forming a compact globular protein
- Two functional EF-hand motifs that bind calcium
- Molecular weight: ~11.5 kDa
- Isoforms: Alpha and beta parvalbumin
- Fast-spiking interneurons: PVALB is a marker for fast-spiking GABAergic interneurons (basket cells and axo-axonic cells)
- Calcium buffering: Protects neurons from calcium overload during high-frequency firing
- Synaptic inhibition: These interneurons provide powerful inhibitory control over pyramidal neurons
- Gamma oscillations: Essential for generation of gamma-frequency oscillations (30-80 Hz)
- Perineuronal nets: Often surrounded by extracellular matrix structures
- Interneuron loss: PVALB+ interneurons are particularly vulnerable in AD
- Inhibitory deficits: Loss contributes to network dysfunction and seizures
- Gamma rhythm disruption: Impaired gamma oscillations affect memory consolidation
- Therapeutic target: Restoring PVALB+ interneuron function is being explored
- Dopamine modulation: PVALB+ interneurons modulate striatal output
- Motor deficits: Changes in inhibition contribute to motor symptoms
- Cognitive impairment: Altered cortical interneuron function in PD dementia
- PVALB downregulation: Consistently reduced in schizophrenia
- Circuit dysfunction: Contributes to cognitive deficits
- Developmental hypothesis: Altered maturation of interneurons
- Protective role: PVALB+ interneurons are often lost in epilepsy
- Seizure susceptibility: Loss of inhibition leads to hyperexcitability
- Cortical hyperexcitability: Reduced PVALB+ interneuron function
- Motor cortex dysfunction: Contributes to disease progression
- GABAergic modulation: Enhancing PVALB+ interneuron function
- Calcium dysregulation therapies: Targeting calcium buffering
- Gamma rhythm restoration: Novel therapeutic approach for cognitive deficits
- Parvalbumin interneurons in Alzheimer's disease (Loreth et al., 2022)
- Fast-spiking interneurons and brain oscillations (Bartos et al., 2007)
- PVALB in schizophrenia (Lewis et al., 2012)
- Celio MR. Parvalbumin in mammalian brain. Brain Res Rev. 1999
- Deustch S, et al. Parvalbumin deficiency leads to reduced anxiety. Behav Brain Res. 2010
- Bialowas A, et al. Parvalbumin and calbindin in the hippocampal formation. Brain Struct Funct. 2021
- Velíšek L, et al. Parvalbumin deficiency and epileptogenesis. Epilepsy Curr. 2008